Market Pulse: Confirmed Uptrend
Distribution Days: 8
On June 11th, the Nifty reclaimed its recent high at 25,116 and is now trending firmly above all its key moving averages, signaling a strong resurgence in bullish momentum. As a result, the overall market condition has been upgraded from Uptrend Under Pressure to a Confirmed Uptrend, reflecting renewed strength and positive sentiment. Market breadth continues to improve, with leading stocks across multiple sectors showing strong momentum.
In the current environment, stocks breaking out of early-stage bases, exhibiting higher relative strength, and backed by strong fundamentals are well-positioned for potential outperformance. Rather than speculating on market movements, we will closely track price action and adapt to evolving conditions.
However, should the distribution day count increase or Nifty breach key support levels, we may downgrade the market status to "Uptrend Under Pressure" to reflect heightened risk.
Buy Watchlist
Astrazeneca Pharma India, Banco Products (India) Ltd, Aarti Pharmalabs, Au Small Finance Bank, Fortis Healthcare (Nse), Interarch Building Solutions Ltd and more.
Key News & Earnings Updates
Godrej Properties to develop 14-acre land parcel in Hoskote, Bengaluru.
Sun Pharm.Industries : US FDA issued eight observations after inspecting its Halol plant from June 2 to 13.
ITC completed the acquisition of a 100% equity stake in Sresta Natural Bioproducts Private Limited (SNBPL) for ₹400 crore.
Birla Corporation (Nse) has been declared the preferred bidder for the Gourum Khan Ki Dhani (South) limestone block in Jaisalmer, Rajasthan
Investing Insights
RCB’s Maiden IPL Trophy: A Stock Market Analogy of Patience, Volatility, and Breakout Success
India GDP Data Highlights
Indian Stock Market Surges on Global Cues and Domestic Optimism
FMCG Climb on Defensive Demand Amid Market Volatility
What do you think? Please email us any questions or comments.
Disclaimer: Information contained herein is not and should not be construed as an offer, solicitation, or recommendation to buy or sell securities. It is for educational purposes only.